| Smiles |
O=C(C=C(C)C)CC(C8(C7(C(C=6(C(C5(C(C(C(OC2(OCC(OC1(OC(C(O)C(C1NC(=O)C)O)CO))C(C2OC3(OC(C(O)C(C3NC(=O)C)O)COC4(OCC(O)C(C4O)O)))O))CC5)(C)C)CC=6)(C))=CC7))CC8)(C)))C
|
| CAS number |
116237-60-6
|
| Polar Surface Area |
331,18
|
| calculated LogS |
-5,306
|
| Molweight |
1095,28
|
| calculated LogP |
0,6381
|
| H-Acceptors |
22
|
| H-Donors |
11
|
| Ro5 violations |
3
|
| Druglikeness |
-11,237
|
| DrugScore |
0,1062195
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
high
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,1708
|
| Rat Acute Toxicity |
2,8224
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,1548
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,5852
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
High HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA-
|
| Structure |
116237-60-6
|
